Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18410980.
- Also identified by DOI 10.1016/j.jaad.2008.03.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In patients with psoriasis, there is an increased availability of drugs for treatment. However, there are important questions about drug safety for mothers with psoriasis and their fetuses. Currently, there are limited safety data for many of the medications used. In this article, we review current pregnancy risk information for medications commonly used in the treatment of psoriasis. In addition, a list of teratology information resources is included to help practicing clinicians find up-to-date information regarding the safety of the medications they prescribe.
Medical subject headings
- Keratolytic Agents
- Pregnancy Complications
- Psoriasis